Boston, MA, United States of America

Par Holmberg

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Valo Health, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Par Holmberg. Retrieved from https://idiyas.com/inventor/par-holmberg-040x953h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Par Holmberg: Patent Activity in Pharmaceutical Chemistry.

Introduction

Par Holmberg is an inventor associated with Boston, Massachusetts, and Valo Health, Inc. His listed patent concerns the preparation of compounds relevant to research on Rho-kinase inhibitors.

Latest Patents

Holmberg is associated with one patent, titled “Process for Preparing 6-Substituted-1-(2H)-Isoquinolinones and Intermediate Compound.” The invention describes substituted isoquinoline oxide compounds and a process for preparing them. These compounds can serve as intermediates in making 6-substituted-1-(2H)-isoquinolinones, which are described as Rho-kinase inhibitors or as intermediates for preparing further inhibitors of the enzyme. The record provided does not establish when this patent was granted or whether it is his most recent patent. His listed total is 1 patent.

Career Highlights

The available information connects Holmberg with Valo Health, Inc., a company working in the health and biotechnology sector. His patent reflects work involving synthetic chemistry and compounds with potential relevance to pharmaceutical research.

Collaborations

Sumit Kumar and Matthew James Wathier are identified as Holmberg’s coworkers. The information provided does not specify their roles in the patent or whether they collaborated with him on this invention.

Conclusion

Par Holmberg’s listed patent focuses on preparing chemical intermediates associated with Rho-kinase inhibitors, highlighting his connection to pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…